Pacific Bio (PACB) Reports Prelim Q1 Revenue, Affirms FY25 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/4/2026

1. LULU
2. ZS
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. NVDA
9. CIEN
10. GWRE

Go back to Pacific Bio (PACB) Reports Prelim Q1 Revenue, Affirms FY25 Guidance
PACIFIC BIO CA (NASDAQ: PACB) Delayed: 1.35 +0.05 (3.85%)
Previous Close $1.30    52 Week High $14.00 
Open $1.29    52 Week Low $6.61 
Day High $1.35    P/E N/A 
Day Low $1.29    EPS $-1.26 
Volume 2,764,524